Showing results (11-20 of 96) with videos related to
Sort By:
Pageof 10
Bioorganic & Medicinal Chemistry|October 15, 2010
Molecular modeling study on potent and selective adenosine A(3) receptor agonistsDiego Dal Ben, Michela Buccioni, Catia Lambertucci, et al.Bioorganic Chemistry|January 31, 2026
Adenine nucleotides as potent and selective GPR17 modulatorsDiego Dal Ben, Catia Lambertucci, Michela Buccioni, et al.Bioorganic & Medicinal Chemistry Letters|December 14, 2007
Rapid novel divergent synthesis and muscarinic agonist profile of all four optical isomers of N,N,N-trimethyl(6-methyl-1,4-dioxan-2-yl)methanaminium iodideAlessandro Piergentili, Wilma Quaglia, Mario Giannella, et al.Expert Opinion on Therapeutic Patents|April 7, 2022
A patent review of adenosine A2B receptor antagonists (2016-present)Beatrice Francucci, Diego Dal Ben, Catia Lambertucci, et al.Pharmaceuticals (Basel, Switzerland)|October 11, 2019
Non-Nucleoside Agonists of the Adenosine Receptors: An OverviewDiego Dal Ben, Catia Lambertucci, Michela Buccioni, et al.European Journal of Medicinal Chemistry|October 12, 2010
Synthesis and α1-adrenoceptor antagonist activity of tamsulosin analoguesGianni Sagratini, Piero Angeli, Michela Buccioni, et al.Bioorganic & Medicinal Chemistry|March 12, 2002
Structure--activity relationships among novel phenoxybenzamine-related beta-chloroethylaminesDario Giardinà, Mauro Crucianelli, Piero Angeli, et al.Expert Opinion on Therapeutic Patents|January 15, 2019
GPR17 receptor modulators and their therapeutic implications: review of recent patentsGabriella Marucci, Diego Dal Ben, Catia Lambertucci, et al.Molecules (Basel, Switzerland)|March 6, 2021
Combined Therapy of A1AR Agonists and A2AAR Antagonists in NeuroinflammationGabriella Marucci, Diego Dal Ben, Catia Lambertucci, et al.Expert Opinion on Therapeutic Patents|November 16, 2019
Update on novel purinergic P2X3 and P2X2/3 receptor antagonists and their potential therapeutic applicationsGabriella Marucci, Diego Dal Ben, Michela Buccioni, et al.Pageof 10